Your browser doesn't support javascript.
loading
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study.
Bussel, James B; de Miguel, Purificación Garcia; Despotovic, Jenny M; Grainger, John D; Sevilla, Julián; Blanchette, Victor S; Krishnamurti, Lakshmanan; Connor, Philip; David, Michèle; Boayue, Koh B; Matthews, Dana C; Lambert, Michele P; Marcello, Lisa M; Iyengar, Malini; Chan, Geoffrey W; Chagin, Karen D; Theodore, Dickens; Bailey, Christine K; Bakshi, Kalpana K.
Afiliación
  • Bussel JB; Pediatric Hematology/Oncology, Weill Cornell Medical College, New York, NY, USA. Electronic address: jbussel@med.cornell.edu.
  • de Miguel PG; Servicio de Infantil, Hospital Universitario La Paz, Madrid, Spain.
  • Despotovic JM; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
  • Grainger JD; Department of Haematology, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK; Central Manchester University Hospitals NHS Foundation Trust, NIHR/Wellcome Trust Manchester CRF, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
  • Sevilla J; Hospital Infantil Universitario Niño Jesús, Hemato-Oncologia Pediatrica, Fundación Investigación Biomédica, Madrid, Spain.
  • Blanchette VS; Department of Pediatrics, University of Toronto and Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.
  • Krishnamurti L; Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA.
  • Connor P; Department of Haematology, Noah's Ark Children's Hospital for Wales, Cardigan House, University of Wales, Cardiff, UK.
  • David M; CHU Sainte-Justine, Montreal, QC, Canada.
  • Boayue KB; Department of Pediatrics, University of New Mexico, Albuquerque, NM, USA.
  • Matthews DC; Seattle Children's Hospital, Seattle, WA, USA.
  • Lambert MP; The Children's Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Marcello LM; GlaxoSmithKline, Collegeville, PA, USA.
  • Iyengar M; GlaxoSmithKline, Collegeville, PA, USA.
  • Chan GW; GlaxoSmithKline, Collegeville, PA, USA.
  • Chagin KD; GlaxoSmithKline, Collegeville, PA, USA.
  • Theodore D; GlaxoSmithKline, Research Triangle Park, NC, USA.
  • Bailey CK; GlaxoSmithKline, Collegeville, PA, USA.
  • Bakshi KK; GlaxoSmithKline, Collegeville, PA, USA.
Lancet Haematol ; 2(8): e315-25, 2015 Aug.
Article en En | MEDLINE | ID: mdl-26688484
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Benzoatos / Púrpura Trombocitopénica Idiopática / Receptores de Trombopoyetina / Hidrazinas Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: America do norte / Europa Idioma: En Revista: Lancet Haematol Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirazoles / Benzoatos / Púrpura Trombocitopénica Idiopática / Receptores de Trombopoyetina / Hidrazinas Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: America do norte / Europa Idioma: En Revista: Lancet Haematol Año: 2015 Tipo del documento: Article Pais de publicación: Reino Unido